(en) Noehren, « Effect of Transcutaneous Electrical Nerve Stimulation on Pain, Function, and Quality of Life in Fibromyalgia: A Double-Blind Randomized Clinical Trial », Physical Therapy - ptjournal.apta.org, (lire en ligne)
(en) Mountz JM, Bradley LA, Modell JG et al., « Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels », Arthritis Rheum., vol. 38, no 7, , p. 926–38 (PMID7612042, DOI10.1002/art.1780380708)
(en) Kwiatek R, Barnden L, Tedman R et al., « Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami », Arthritis Rheum., vol. 43, no 12, , p. 2823–33 (PMID11145042, DOI10.1002/1529-0131(200012)43:12<2823::AID-ANR24>3.0.CO;2-E)
(en) Gracely RH, Petzke F, Wolf JM, Clauw DJ, « Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia », Arthritis Rheum., vol. 46, no 5, , p. 1333–43 (PMID12115241, DOI10.1002/art.10225)
(en) Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH, « Functional imaging of pain in patients with primary fibromyalgia », J Rheumatol., vol. 31, no 2, , p. 364–78 (PMID14760810, DOI10.1093/rheumatology/31.6.364, lire en ligne)
(en) M Pimentel, « A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing », Annals of the Rheumatic Diseases, vol. 63, no 4, , p. 450–452 (ISSN0003-4967, DOI10.1136/ard.2003.011502, lire en ligne, consulté le )
(en) Luis Rodrigo, Ignacio Blanco, Julio Bobes et Frederick J de Serres, « Clinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac disease », BMC Gastroenterology, vol. 13, no 1, (ISSN1471-230X, DOI10.1186/1471-230x-13-157, lire en ligne, consulté le )
(en) Luis Rodrigo, Ignacio Blanco, Julio Bobes et Frederick J de Serres, « Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study », Arthritis Research & Therapy, vol. 15, no 6, , R201 (ISSN1478-6354, PMID24283458, PMCIDPMC3978893, DOI10.1186/ar4391, lire en ligne, consulté le )
(en) Drewes AM, Gade K, Nielsen KD, Bjerregård K, Taagholt SJ, Svendsen L, « Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome », Br J Rheumatol., vol. 34, no 12, , p. 1151–6 (PMID8608357, DOI10.1093/rheumatology/34.12.1151, lire en ligne)
(en) Younger J, Noor N, McCue R, Mackey S, « Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels », Arthritis Rheum, vol. 65, no 2, , p. 529-38. (PMID23359310, DOI10.1002/art.37734, lire en ligne [html])modifier
(en) Monica Bolton, Alex Hodkinson, Shivani Boda et Alan Mould, « Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis », BMC Medicine, vol. 17, no 1, (ISSN1741-7015, DOI10.1186/s12916-018-1242-0, lire en ligne, consulté le )
(en) Ana Paula Marum, Cátia Moreira, Pablo Tomas-Carus et Fernando Saraiva, « A low fermentable oligo-di-mono-saccharides and polyols (FODMAP) diet is a balanced therapy for fibromyalgia with nutritional and symptomatic benefits », Nutricion Hospitalaria, vol. 34, no 3, 06 05, 2017, p. 667–674 (ISSN1699-5198, PMID28627205, DOI10.20960/nh.703, lire en ligne, consulté le )
(en) Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Fields JZ, Forre OT., « Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II--a 24-month follow-up pilot study. », Clin Exp Rheumatol., vol. 31(5), , p. 821-7 (PMID22278161, DOI10.1007/s10067-011-1907-y, lire en ligne)
(en) John C Deare, Zhen Zheng, Charlie CL Xue, Jian Ping Liu, Jingsheng Shang, Sean W Scott et Geoff Littlejohn, « Acupuncture for treating fibromyalgia », Cochrane Database of Systematic Reviews, (DOI10.1002/14651858.CD007070.pub2)
(en) Hajra Khurshid, Israa A Qureshi, Nasrin Jahan et Terry R Went, « A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope? », Cureus, vol. 13, no 8, , e17332 (ISSN2168-8184, PMID34567876, PMCID8451533, DOI10.7759/cureus.17332, lire en ligne, consulté le )
(en) Winfield JB, « Fibromyalgia and related central sensitivity syndromes: twenty-five years of progress », Semin. Arthritis Rheum., vol. 36, no 6, , p. 335–8 (PMID17303220, DOI10.1016/j.semarthrit.2006.12.001, lire en ligne, consulté le )
(en) Winfield JB, « Fibromyalgia and related central sensitivity syndromes: twenty-five years of progress », Semin. Arthritis Rheum., vol. 36, no 6, , p. 335–8 (PMID17303220, DOI10.1016/j.semarthrit.2006.12.001, lire en ligne, consulté le )
europa.eu
emea.europa.eu
[PDF]« The CHMP was concerned that the benefits of Lyrica in fibromyalgia had not been shown in either the short or the long term. There were no consistent or relevant reductions in pain or other symptoms in the short-term studies. In addition, the change in symptoms did not seem to be related to the dose of Lyrica that the patients received, and the maintenance of Lyrica’s effect was not shown in the longer study. The Committee was also concerned that the safety and effectiveness of Lyrica had not been shown in patients from the EU. At that point in time, the CHMP was of the opinion that the benefits of Lyrica in the treatment of fibromyalgia did not outweigh its risks. Hence, the CHMP recommended that the change to the marketing authorisation be refused »[1]
(en) A. Neuprez et J.-M. Crielaard, « [Fibromyalgia : state of the issue in 2017] », Revue Medicale De Liege, vol. 72, no 6, , p. 288–294 (ISSN0370-629X, PMID28628285, lire en ligne, consulté le )
(en) M Pimentel, « A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing », Annals of the Rheumatic Diseases, vol. 63, no 4, , p. 450–452 (ISSN0003-4967, DOI10.1136/ard.2003.011502, lire en ligne, consulté le )
(en) Luis Rodrigo, Ignacio Blanco, Julio Bobes et Frederick J de Serres, « Clinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac disease », BMC Gastroenterology, vol. 13, no 1, (ISSN1471-230X, DOI10.1186/1471-230x-13-157, lire en ligne, consulté le )
(en) Luis Rodrigo, Ignacio Blanco, Julio Bobes et Frederick J de Serres, « Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study », Arthritis Research & Therapy, vol. 15, no 6, , R201 (ISSN1478-6354, PMID24283458, PMCIDPMC3978893, DOI10.1186/ar4391, lire en ligne, consulté le )
(en) Monica Bolton, Alex Hodkinson, Shivani Boda et Alan Mould, « Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis », BMC Medicine, vol. 17, no 1, (ISSN1741-7015, DOI10.1186/s12916-018-1242-0, lire en ligne, consulté le )
(en) Ana Paula Marum, Cátia Moreira, Pablo Tomas-Carus et Fernando Saraiva, « A low fermentable oligo-di-mono-saccharides and polyols (FODMAP) diet is a balanced therapy for fibromyalgia with nutritional and symptomatic benefits », Nutricion Hospitalaria, vol. 34, no 3, 06 05, 2017, p. 667–674 (ISSN1699-5198, PMID28627205, DOI10.20960/nh.703, lire en ligne, consulté le )
(en) Hajra Khurshid, Israa A Qureshi, Nasrin Jahan et Terry R Went, « A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope? », Cureus, vol. 13, no 8, , e17332 (ISSN2168-8184, PMID34567876, PMCID8451533, DOI10.7759/cureus.17332, lire en ligne, consulté le )
(en) Michael D. Reynolds, « The Develoment of the Concept of Fibrositis », The Journal of the History of Medicine and Allied Sciences, vol. 38, , p. 5-9 (ISSN0022-5045)
(en) Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH, « Functional imaging of pain in patients with primary fibromyalgia », J Rheumatol., vol. 31, no 2, , p. 364–78 (PMID14760810, DOI10.1093/rheumatology/31.6.364, lire en ligne)
(en) A. Neuprez et J.-M. Crielaard, « [Fibromyalgia : state of the issue in 2017] », Revue Medicale De Liege, vol. 72, no 6, , p. 288–294 (ISSN0370-629X, PMID28628285, lire en ligne, consulté le )
(en) Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al.« The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee » Arthritis Rheum. 1990;33:160-72. PMID2306288
Gregory Kaltsas et Konstantinos Tsiveriotis, « Fibromyalgia », dans Endotext, MDText.com, Inc., (PMID25905317, lire en ligne)
Juhi Bhargava et John A. Hurley, « Fibromyalgia », dans StatPearls, StatPearls Publishing, (PMID31082018, lire en ligne)
(en) Mountz JM, Bradley LA, Modell JG et al., « Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels », Arthritis Rheum., vol. 38, no 7, , p. 926–38 (PMID7612042, DOI10.1002/art.1780380708)
(en) Kwiatek R, Barnden L, Tedman R et al., « Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami », Arthritis Rheum., vol. 43, no 12, , p. 2823–33 (PMID11145042, DOI10.1002/1529-0131(200012)43:12<2823::AID-ANR24>3.0.CO;2-E)
(en) Gracely RH, Petzke F, Wolf JM, Clauw DJ, « Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia », Arthritis Rheum., vol. 46, no 5, , p. 1333–43 (PMID12115241, DOI10.1002/art.10225)
(en) Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH, « Functional imaging of pain in patients with primary fibromyalgia », J Rheumatol., vol. 31, no 2, , p. 364–78 (PMID14760810, DOI10.1093/rheumatology/31.6.364, lire en ligne)
(en) Luis Rodrigo, Ignacio Blanco, Julio Bobes et Frederick J de Serres, « Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study », Arthritis Research & Therapy, vol. 15, no 6, , R201 (ISSN1478-6354, PMID24283458, PMCIDPMC3978893, DOI10.1186/ar4391, lire en ligne, consulté le )
(en) Moldofsky H, Scarisbrick P, England R, Smythe H, « Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects », Psychosom Med, vol. 37, no 4, , p. 341–51 (PMID169541, lire en ligne)
(en) Moldofsky H, Scarisbrick P, « Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation », Psychosom Med, vol. 38, no 1, , p. 35–44 (PMID176677, lire en ligne)
(en) Drewes AM, Gade K, Nielsen KD, Bjerregård K, Taagholt SJ, Svendsen L, « Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome », Br J Rheumatol., vol. 34, no 12, , p. 1151–6 (PMID8608357, DOI10.1093/rheumatology/34.12.1151, lire en ligne)
(en) Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA, Mease PJ, McLean SA, Clauw DJ, « Efficacy of milnacipran in patients with fibromyalgia », J Rheumatol, vol. 32, no 10, , p. 1975-85 (PMID16206355, lire en ligne [html], consulté le )modifier
(en) Younger J, Noor N, McCue R, Mackey S, « Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels », Arthritis Rheum, vol. 65, no 2, , p. 529-38. (PMID23359310, DOI10.1002/art.37734, lire en ligne [html])modifier
(en) Ana Paula Marum, Cátia Moreira, Pablo Tomas-Carus et Fernando Saraiva, « A low fermentable oligo-di-mono-saccharides and polyols (FODMAP) diet is a balanced therapy for fibromyalgia with nutritional and symptomatic benefits », Nutricion Hospitalaria, vol. 34, no 3, 06 05, 2017, p. 667–674 (ISSN1699-5198, PMID28627205, DOI10.20960/nh.703, lire en ligne, consulté le )
(en) Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Forre OT., « Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway. A six-month follow-up study. », Clin Exp Rheumatol., vol. 5 Suppl 56), , S46-50 (PMID20074439, lire en ligne)
(en) Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Fields JZ, Forre OT., « Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II--a 24-month follow-up pilot study. », Clin Exp Rheumatol., vol. 31(5), , p. 821-7 (PMID22278161, DOI10.1007/s10067-011-1907-y, lire en ligne)
(en) Hajra Khurshid, Israa A Qureshi, Nasrin Jahan et Terry R Went, « A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope? », Cureus, vol. 13, no 8, , e17332 (ISSN2168-8184, PMID34567876, PMCID8451533, DOI10.7759/cureus.17332, lire en ligne, consulté le )
(en) Winfield JB, « Fibromyalgia and related central sensitivity syndromes: twenty-five years of progress », Semin. Arthritis Rheum., vol. 36, no 6, , p. 335–8 (PMID17303220, DOI10.1016/j.semarthrit.2006.12.001, lire en ligne, consulté le )
(en) A. Neuprez et J.-M. Crielaard, « [Fibromyalgia : state of the issue in 2017] », Revue Medicale De Liege, vol. 72, no 6, , p. 288–294 (ISSN0370-629X, PMID28628285, lire en ligne, consulté le )
(en) Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Forre OT., « Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway. A six-month follow-up study. », Clin Exp Rheumatol., vol. 5 Suppl 56), , S46-50 (PMID20074439, lire en ligne)
(en) Rasmussen LB, Mikkelsen K, Haugen M, Pripp AH, Fields JZ, Forre OT., « Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II--a 24-month follow-up pilot study. », Clin Exp Rheumatol., vol. 31(5), , p. 821-7 (PMID22278161, DOI10.1007/s10067-011-1907-y, lire en ligne)
(en) Moldofsky H, Scarisbrick P, England R, Smythe H, « Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects », Psychosom Med, vol. 37, no 4, , p. 341–51 (PMID169541, lire en ligne)
(en) Moldofsky H, Scarisbrick P, « Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation », Psychosom Med, vol. 38, no 1, , p. 35–44 (PMID176677, lire en ligne)
(en) Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA, Mease PJ, McLean SA, Clauw DJ, « Efficacy of milnacipran in patients with fibromyalgia », J Rheumatol, vol. 32, no 10, , p. 1975-85 (PMID16206355, lire en ligne [html], consulté le )modifier
(en) Younger J, Noor N, McCue R, Mackey S, « Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels », Arthritis Rheum, vol. 65, no 2, , p. 529-38. (PMID23359310, DOI10.1002/art.37734, lire en ligne [html])modifier
(en) Younger J, Noor N, McCue R, Mackey S, « Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels », Arthritis Rheum, vol. 65, no 2, , p. 529-38. (PMID23359310, DOI10.1002/art.37734, lire en ligne [html])modifier
